Kennedy Investment Group Pfizer Inc Transaction History

Kennedy Investment Group

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$32.09 - $37.51 $8,279 - $9,677	-258 Reduced 3.65%	6,819 $226 Million
Q2 2023 Jul 19, 2023	BUY	$36.12 - $41.79 $30,340 - $35,103	840 Added 13.47%	7,077 $260 Million
Q1 2023 May 31, 2023	SELL	$39.39 - $51.28 $72,241 - $94,047	-1,834 Reduced 22.72%	6,237 $254 Million
Q4 2022 May 31, 2023	BUY	$41.75 - $54.5 $336,964 - $439,869	8,071 New	8,071 $414 Million

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Kennedy Investment Group, based on Form 13F filings with the SEC.

Stay updated on Kennedy Investment Group with notifications on news.